404 related articles for article (PubMed ID: 27457246)
21. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
23. The Genomic Landscape of Actinic Keratosis.
Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
[TBL] [Abstract][Full Text] [Related]
24. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
Bai X; Zhou Y; Chen P; Yang M; Xu J
J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.
Hameetman L; Commandeur S; Bavinck JN; Wisgerhof HC; de Gruijl FR; Willemze R; Mullenders L; Tensen CP; Vrieling H
BMC Cancer; 2013 Feb; 13():58. PubMed ID: 23379751
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
28. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
29. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
30. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
Shibayama Y; Imafuku S
J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
[TBL] [Abstract][Full Text] [Related]
31. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
Yamane K; Jinnin M; Etoh T; Kobayashi Y; Shimozono N; Fukushima S; Masuguchi S; Maruo K; Inoue Y; Ishihara T; Aoi J; Oike Y; Ihn H
J Mol Med (Berl); 2013 Jan; 91(1):69-81. PubMed ID: 22828925
[TBL] [Abstract][Full Text] [Related]
33. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
Kim BK; Kim I; Yoon SK
J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896
[TBL] [Abstract][Full Text] [Related]
34. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
35. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
36. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
37. MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas.
Stojadinovic O; Ramirez H; Pastar I; Gordon KA; Stone R; Choudhary S; Badiavas E; Nouri K; Tomic-Canic M
Arch Dermatol Res; 2017 Mar; 309(2):133-139. PubMed ID: 28013372
[TBL] [Abstract][Full Text] [Related]
38. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X; Wu D; Zhang X; Shao X; Hu G
Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
[TBL] [Abstract][Full Text] [Related]
39. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.
Hervás-Marín D; Higgins F; Sanmartín O; López-Guerrero JA; Bañó MC; Igual JC; Quilis I; Sandoval J
PLoS One; 2019; 14(12):e0223341. PubMed ID: 31860637
[TBL] [Abstract][Full Text] [Related]
40. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]